2012 Montréal
Presentations
The speakers below have given their approval to publish their presentation, held during the congress. Please click on the title, to download the presentation in a pdf.
Surveillance of blood utilisation Usefulness for hemovigilance
Jonathan Wallis (United Kingdom)
Hemovigilance in Québec
Karl Itaj Nawej1 (Canada)
Donor hemoglobin and iron stores
Gilles Delage (Canada)
EIDs: Emerging and Submerging Infections
Roger Y. Dodd (USA)
The Importance of Transfusion Error Surveillance This is step #1 in error management
Jeannie Callum (USA)
Error Surveillance for Continuous Quality Improvement
Ann Mountain Wilson (Canada)
Effectiveness of the donor questionnaire to ensure donor safety
Mindy Goldman (Canada)
WHO Initiative on Vigilance for Organs, Tissues and Cells: Project NOTIFY
D. Michael Strong (USA)
Blood, sweat and tears? Clinical governance and haemovigilance
Erica Wood (Australia)
Setting up a hemoviligance system in a hospital network
Ginette Labonté (Canada)
Screening allogeneic blood donors for pulse rate abnormalities: does it prevent cardiac ischemic events?
Marc Germain (Canada)
Blood donation or blood donor deferral based on data on nonconformities detected in post-selection period
Tomislav Vuk (Croatia)
Wrong blood in Tube the tip of the iceberg
Paula Bolton-Maggs (United Kingdom)
Tissue vigilance in The Netherlands
Johanna Wiersum-Osselton (The Netherlands)
Donor vigilance: five-year journey of continuous process improvement
Hany Kamel (USA)
Nationwide adoption of pathogen inactivation for platelet concentrates in Switzerland
Morven Rüesch (Switzerland)
Biovigilance in the USA: progress on recipient hemovigilance
Matthew J. Kuehnert (USA)
The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components (ISTARE)
Constantina Politis (Greece)
National Healthcare Safety Network Hemovigilance Module Progress Report, 2010-2011
Alexis Harvey (Canada)
Serious Hazards of Transfusion Paediatric Data
Paula Bolton-Maggs (United Kingdom)
U.S. Biovigilance Network; investing in patient safety and donor health
Barbee Whitaker (USA)
Donor Vigilance
Peter Tomasulo (USA)
Does TRALI occur in children? A Canadian perspective
Lani Lieberman (USA)
Hemovigilance: Where are we in 2012?
Claude Jean Faber (Luxembourg)
Recognising and reporting acute transfusion reactions: Experience from STIR
Erica Wood